University of Nebraska: Multiple Myeloma trials

The registry lists 10 Multiple Myeloma studies with University of Nebraska as lead sponsor. 4 are open to participants now and 5 have results posted.

Phase 1 1Phase 2 5No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Halt Aging in Survivors of Blood CancersRecruitingNCT07292272Not applicable
• Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular TherapyRecruitingNCT05135351Not applicable
• Improving Cognitive Function in Older Adults Undergoing Stem Cell TransplantRecruitingNCT04898790Not applicable
• Integrated Cancer Repository for Cancer ResearchRecruitingNCT02012699
• Cabozantinib as a Targeted Strategy to Reverse Carfilzomib Resistance in Refractory Multiple MyelomaTerminatedNCT03201250Phase 1/2Results posted
• Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and RecoveryCompletedNCT02767388Results posted
• Enhancing Anti--Tetanus Vaccine Response After Autologous Stem Cell TransplantationTerminatedNCT02700841Phase 2Results posted
• Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic CancerCompletedNCT00611351Phase 2Results posted
• Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell TransplantCompletedNCT00571662Phase 2Results posted
• Iberdomide Maintenance Therapy in Patients With Multiple MyelomaActive, not recruitingNCT05177536Phase 2